Skip to Primary Navigation

Third circuit says pharma fax violated TCPA

A black and white photo of an early fax machine and a person's hands holding several pages of fax paper.
Photo: Xerox/PhotoQuest/Getty Images

The Third Circuit has ruled a fax about a blood thinner could qualify as an unsolicited advertisement under the TCPA.

The US Court of Appeals for the Third Circuit has ruled that a fax sent by a major healthcare support services company to a Florida pharmacy about an anticoagulant prescription drug could be considered an unsolicited advertisement under the Telephone Consumer Protection Act, reviving a class action that a

In

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience